Clinical Trials Logo

Clinical Trial Summary

Several clinical procedures have been described as aerosol generating procedure (AGP), including nebulization, high-flow nasal cannula oxygen therapy, noninvasive ventilation, and bronchial hygiene treatment, etc. However, the understanding on the transmission risk of these treatments is still unclear, particularly the methods to reduce the airborne particulate concentrations during these treatments are still lacking. This study is aimed to compare different modalities in reducing airborne particulate concentrations during these aerosol generating procedures, in order to find the most effective method to reduce particle concentrations, ultimately to decrease the transmission risk and protect health care providers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Transmission, Patient-Professional

NCT number NCT04681599
Study type Interventional
Source Rush University Medical Center
Contact
Status Completed
Phase N/A
Start date January 24, 2021
Completion date April 13, 2021

See also
  Status Clinical Trial Phase
Completed NCT04654754 - Aerosol Particle Concentrations Among Different Oxygen Devices for Spontaneous Breathing Patients With Tracheostomy N/A
Terminated NCT04526925 - The Effects of Filter During CPET on WOB and Aerosol Particle Concentrations N/A